LASTACAFT, ALCAFTADINE.. Drug Patent Expiration, 21st Nov 2013 « New Drug Approvals

LASTACAFT, ALCAFTADINE.. Drug Patent Expiration, 21st Nov 2013 « New Drug Approvals:

'via Blog this'

Alzheimer’s Image Problem Solved » All About Drugs

Alzheimer’s Image Problem Solved » All About Drugs:

'via Blog this'

Pfizer 2013 and beyond » All About Drugs

Pfizer 2013 and beyond » All About Drugs:

'via Blog this'

ViiV Healthcare files new drug application for three-drug HIV pill with US FDA » All About Drugs

ViiV Healthcare files new drug application for three-drug HIV pill with US FDA » All About Drugs:

'via Blog this'

RABEPRAZOLE « New Drug Approvals

RABEPRAZOLE « New Drug Approvals:

'via Blog this'

Cubist Pharmaceuticals, Inc. announced that it has submitted a NDA to the U.S. FDA for approval of its investigational antibiotic tedizolid phosphate (TR-701). « New Drug Approvals

Cubist Pharmaceuticals, Inc. announced that it has submitted a NDA to the U.S. FDA for approval of its investigational antibiotic tedizolid phosphate (TR-701). « New Drug Approvals:

'via Blog this'

ACIPHEX, RABEPRAZOLE SODIUM, patent exp 8 th Nov 2013 « New Drug Approvals

ACIPHEX, RABEPRAZOLE SODIUM, patent exp 8 th Nov 2013 « New Drug Approvals:

'via Blog this'